(Bloomberg) -- China hawks in the US House overcame a last-ditch lobbying effort and passed legislation Monday night that would blacklist Chinese biotech companies and their US subsidiaries.

Most Read from Bloomberg

How Americans Voted Their Way Into a Housing Crisis

World's Second Tallest Tower Spurs Debate About Who Needs It

UC Berkeley Gives Transfer Students a Purpose-Built Home on Campus